Belantamab mafodotin, nirogacestat and pomalidomide for patients with relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Hultcrantz, M.; Hassoun, H.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; Hashmi, H.; Maclachlan, K. H.; Rajeeve, S.; Shah, U. A.; Patel, D.; Derkach, A.; Hamid, S.; Shekarkhand, T.; Tran, L.; Caple, J.; Barnett, K.; Sood, T.; Jenna, B.; Konsky, A.; Murata, K.; Roshal, M.; Giralt, S. A.; Usmani, S. Z.; Mailankody, S. |
| Abstract Title: | Belantamab mafodotin, nirogacestat and pomalidomide for patients with relapsed/refractory multiple myeloma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 7077 |
| Language: | English |
| ACCESSION: | WOS:001412773800002 |
| DOI: | 10.1182/blood-2024-211857 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
